Prestige Biopharma appoints Nexia Samduk as external auditor
Prestige Biopharma appointed Nexia Samduk as external auditor, replacing its prior auditor. The audit contract runs from July 1, 2026 to June 30, 2027.
Prestige Biopharma appointed Nexia Samduk as external auditor, replacing its prior auditor. The audit contract runs from July 1, 2026 to June 30, 2027.